0000899243-21-034143.txt : 20210825
0000899243-21-034143.hdr.sgml : 20210825
20210825161551
ACCESSION NUMBER: 0000899243-21-034143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210823
FILED AS OF DATE: 20210825
DATE AS OF CHANGE: 20210825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burke William P. Mr.
CENTRAL INDEX KEY: 0001682069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 211207058
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
FORMER NAME:
FORMER CONFORMED NAME: Burke Willaim P
DATE OF NAME CHANGE: 20160810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0402
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-23
0
0000313143
HAEMONETICS CORP
HAE
0001682069
Burke William P. Mr.
125 SUMMER STREET
BOSTON
MA
02110
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2021-08-23
4
M
0
11232
34.21
A
41523
D
Common Stock
2021-08-23
4
M
0
11435
41.64
A
52958
D
Common Stock
2021-08-23
4
S
0
22667
60.51
D
30291
D
Non-qualified Stock Option (Right to Buy)
34.21
2021-08-23
4
M
0
11232
0.00
D
2020-10-25
2023-10-25
Common Stock
11232
0
D
Non-qualified Stock Option (Right to Buy)
41.64
2021-08-23
4
M
0
11435
0.00
D
2021-06-06
2024-06-06
Common Stock
11435
0
D
Transaction pursuant to an existing 10b5-1 trading plan.
Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
This number includes unvested RSUs previously reported.
/s/ Michelle Basil, attorney-in-fact for Mr. Burke
2021-08-25